Nominal Korean-made drugs may not be granted any longer.

The KFDA announced on Aug. 9 that the KFDA would not grant it as a Korean-made drug when a drug maker imported finished bulk drugs simply to pack locally according to the revised Working Rules of the Pharmaceutical Affairs Act.

Article 71 (drug descriptions and labelling), paragraph 5 of the Working Rules of the Pharmaceutical Affairs Act specifies "Under the toll manufacturing of drugs thro...